Peripheral leukemia burden at time of apheresis negatively affects the clinical efficacy of CART19 in refractory or relapsed B-ALL

Autor: Deng, Biping 1, Pan, Jing 2, Liu, Zhaoli 1, Liu, Shuangyou 2, Chen, Yunlong 1, Qu, Xiaomin 1, Zhang, Yu'e 1, Lin, Yuehui 2, Zhang, Yanlei 3, Yu, Xinjian 4, Zhang, Zhongxin 1, Niu, Xuansha 1, Luan, Rong 1, Ma, Ming 1, Li, Xiaomei 1, Liu, Tingting 1, Wu, Xi'ai 1, Niu, Huan 1, Chang, Alex H. 3, ∗, Tong, Chunrong 2, ∗∗
Zdroj: In Molecular Therapy - Methods & Clinical Development 10 December 2021 23:633-643
Databáze: ScienceDirect